Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
05/2000
05/11/2000CA2347188A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000CA2347060A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000CA2345337A1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors
05/11/2000CA2312430A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
05/10/2000EP0999205A1 Aminocycloalkane compounds
05/10/2000EP0998926A1 Oral preparation comprising S-(3-hydroxypropyl)-L-cysteine
05/10/2000EP0998484A1 Tharapeutically active compounds with low systemic activity due to reduced half-life
05/10/2000EP0998477A1 Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents
05/10/2000EP0998475A1 Novel compounds
05/10/2000EP0998460A1 Novel tetrazole derivatives
05/10/2000EP0998300A1 Methods and compositions for modulating responsiveness to corticosteroids
05/10/2000EP0998282A1 Sulfonamides as cell adhesion inhibitors
05/10/2000EP0998272A1 Pharmaceutical composition for combination of piperidinoalkanol-decongestant
05/10/2000EP0743939B1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
05/10/2000CN1252809A Modified TNF alpha molecules, DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
05/10/2000CN1252799A N-heterocyclic derivatives as NOS inhibitor
05/10/2000CN1252721A Pharmaceutical composition
05/10/2000CN1252709A Confectionary compositions
05/10/2000CN1252708A Throat soothing compositions
05/10/2000CN1252304A Pure Chinese medicine powder for throat diseases
05/10/2000CN1252299A Antiphlogistic cough-relieving medicine
05/10/2000CN1252286A Medicine for pulmonary diseases and its preparation
05/09/2000US6060494 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
05/09/2000US6060479 Quinazoline-4-one AMPA antagonists
05/09/2000US6060475 Substituted pyrazin-2-yl-sulphonamide-(3-pyridyl) compounds and uses thereof
05/09/2000US6060460 Use of betaglycan to reduce scarring
05/09/2000US6060453 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose
05/09/2000US6060280 Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins
05/09/2000US6060061 Method for preventing or treating disorders involving an inflammatory process
05/09/2000CA2112239C Enantiomeric hydroxylated xanthine compounds
05/04/2000WO2000024911A2 Human phospholipases
05/04/2000WO2000024902A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000024901A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000024897A1 Cell surface molecule-induced macrophage activation
05/04/2000WO2000024758A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF
05/04/2000WO2000024745A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
05/04/2000WO2000024744A1 Bicyclic nitrogen heterocycles
05/04/2000WO2000024743A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
05/04/2000WO2000024742A1 Pyrazolopyridine as adenosine antagonists
05/04/2000WO2000024741A2 Dihydropyridine compounds and their use as potassium channel openers
05/04/2000WO2000024712A1 Vitamin d3 derivatives and remedies for inflammatory respiratory diseases containing the same
05/04/2000WO2000024710A1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
05/04/2000WO2000024403A1 Use of antifungal agents for treating scleroses
05/04/2000WO2000024402A1 Use of antifungal agents for treating scleroses
05/04/2000WO2000024393A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
05/04/2000WO2000024391A2 Conductance of improperly folded proteins through the secretory pathway
05/04/2000WO2000024386A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs
05/04/2000WO2000024375A1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap
05/04/2000WO2000012139B1 Hypoxia regulated genes
05/04/2000WO2000006743A3 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000006730A3 Human cytoskeletal proteins
05/04/2000WO2000006254A3 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
05/04/2000WO2000006085A3 Compounds and methods
05/04/2000WO1999064038A9 Novel analgesic agents
05/04/2000WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS
05/04/2000WO1999043672A9 Inhibitors of phospholipase a2
05/04/2000DE19850072A1 Phosphinat-Peptidanaloga zur Behandlung von fibrotischen Erkrankungen Phosphinate-peptide analogues in the treatment of fibrotic diseases
05/04/2000CA2348989A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000CA2348833A1 Human phospholipases
05/04/2000CA2348747A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000CA2348576A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
05/04/2000CA2348529A1 Conductance of improperly folded proteins through the secretory pathway
05/04/2000CA2348235A1 Vitamin d3 derivatives and treating agent for inflammatory respiratory disease using same
05/04/2000CA2348165A1 Dihydropyridine compounds and methods of use
05/04/2000CA2348160A1 Use of antifungal agents for treating scleroses
05/04/2000CA2347365A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
05/04/2000CA2343100A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs
05/04/2000CA2340225A1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap
05/03/2000EP0996621A1 Novel compounds
05/03/2000EP0996620A1 Novel compounds
05/03/2000EP0996618A1 Endothelin antagonists: n- 2'- (4,5-dimethyl-3-isoxazolyl) amino]sulfonyl]-4-(2-oxazolyl) 1,1'-biphenyl]-2-yl]methyl] -n,3,3-trimethylbutanamide and n-(4,5-dimethyl-3-isoxazolyl) -2'- (3,3-dimethyl-2-oxo-1-pyrrolidinyl) methyl] -4'-(2-oxazolyl) 1,1'-biphenyl]-2-sulfonamide and salts thereof
05/03/2000EP0996460A1 TREATMENT OF ACUTE LUNG INJURY AND FIBROSIS WITH ANTAGONISTS OF $g(a)v$g(b)6
05/03/2000EP0996446A1 Novel substituted imidazole compounds
05/03/2000EP0691985B1 Phosphonomethyldipeptides
05/03/2000CN1251766A Qingying injection for clearing heat and resisting infection and its preparing process
05/03/2000CN1251760A Medicine
05/03/2000CN1052002C 4-aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans, preparation thereof and medicinal composition comprising them
05/03/2000CN1051998C Isoquinolines preparation thereof and its medicinal compositions
05/02/2000US6057457 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
05/02/2000US6057445 Formation of carbon nitrogen bond, cyclization and halogenation
05/02/2000US6057432 CysS
05/02/2000US6057369 Use in the treatment of disease states associated with proteins that mediate cellular activity which are capable of being modulated by inhibiting a matrix metalloproteinase (mmp), tumor necrosis factor (tnf) or cyclic amp
05/02/2000US6057330 Pyrrolopyrazolopyrimidine compound and medicine comprising the same as active ingredient
05/02/2000US6057329 Inhibitors of the protein tyrosine kinases and are of use in the prophylaxis and treatment of immune diseases, hyperproliferative disorders and other diseases
05/02/2000US6057318 Heterocyclic derivatives, process for their preparation and their therapeutic use
05/02/2000US6057124 Nucleic acids encoding ligands for HEK4 receptors
05/02/2000US6056957 Humanized monoclonal antibodies against human interleukin-5
05/02/2000CA2022740C Cyclic neurokinin a antagonists
04/2000
04/27/2000WO2000023599A2 Human proteins involved in endoplasmic reticulum protein degradation
04/27/2000WO2000023572A1 Tnfr related gene 12
04/27/2000WO2000023569A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
04/27/2000WO2000023457A1 Adenine derivatives
04/27/2000WO2000023450A1 Fused pyridazine derivatives, process for the preparation of the same and uses thereof
04/27/2000WO2000023426A1 Novel imidazoles with anti-inflammatory activity
04/27/2000WO2000023113A1 Peptide-based carrier devices for stellate cells
04/27/2000WO2000023091A2 Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases
04/27/2000WO2000023065A2 Storable active substance concentrate with formoterol
04/27/2000WO2000023037A1 Two chamber cartridge for atomizers
04/27/2000WO2000023023A1 Methods of hydrating mucosal surfaces
04/27/2000WO2000003702A8 New pharmaceutical preparation and method
1 ... 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 ... 878